Clinical Trial Update: Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM [Phase 3]

View source ↗

Summary

Phase 3 trial investigating adjuvant systemic chemotherapy with or without HAI-FUDR in patients with resected colorectal liver metastases; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• HAI-FUDR (fudr-based hepatic arterial infusion)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer, Liver Metastases | Phase 3 | Status: TERMINATED